Harnessing copper: Innovative approaches to combat neurodegenerative diseases and cancer (Review)
International Journal of Molecular Medicine · 27.10.2025 · 57 (1) · 1-20
DOI: 10.3892/ijmm.2025.5678 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 27.10.2025. Verfasst von Tao Duan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China. Hauptthemen laut MEDLINE: Copper, Neurodegenerative Diseases, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 256 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Copper is an important trace element in the human body and plays an essential role in cells, where it is involved in synthesizing copper‑dependent enzymes, including superoxide dismutase, cytochrome c oxidase, tyrosinase, lysyl oxidase, dopamine‑β‑hydroxylase and other related copper‑containing enzymes. Copper overload or deficiency affects cell activity, leading to the development of neurodegenerative diseases or cancer. Neurodegenerative diseases, including Alzheimer's, Parkinson's and Huntington's disease, as well as cancer, represent significant chronic health burdens. The complexity of their pathophysiological mechanisms, coupled with the limitations of current targeted therapies, complicates the development of effective treatments. This review provides a comprehensive overview of the current understanding of copper's regulatory mechanisms in health and disease, with particular emphasis on its roles in neurodegenerative disorders and cancer. Recent advances in copper‑targeted therapeutic strategies, including copper chelators, ionophores and copper‑based nanoparticles, were highlighted. Furthermore, the clinical potential, key challenges and future prospects of these interventions were assessed. By synthesizing recent preclinical and clinical evidence, this review aims to contribute novel perspectives for improving the treatment of copper‑associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Embryology, Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China.
- Morphology Laboratory, Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China.
- Department of Immunology, Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China.
Zitieren
APA
Duan, T., Mao, H., Jiang, X., Tian, Y., Zhang, J., & Tan, J. (2025). Harnessing copper: Innovative approaches to combat neurodegenerative diseases and cancer (Review). International Journal of Molecular Medicine, 57(1), 1-20. https://doi.org/10.3892/ijmm.2025.5678
Vancouver
Duan T, Mao H, Jiang X, Tian Y, Zhang J, Tan J. Harnessing copper: Innovative approaches to combat neurodegenerative diseases and cancer (Review). International Journal of Molecular Medicine. 2025;57(1):1-20. doi:10.3892/ijmm.2025.5678
BibTeX
@article{Duan2025,
author = {Duan, Tao and Mao, Hanhai and Jiang, Xingyue and Tian, Ying and Zhang, Jidong and Tan, Jun},
title = {Harnessing copper: Innovative approaches to combat neurodegenerative diseases and cancer (Review)},
journal = {International Journal of Molecular Medicine},
year = {2025},
volume = {57},
number = {1},
pages = {1--20},
doi = {10.3892/ijmm.2025.5678}
}
EUVIMED